The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | A | Alimentary tract and metabolism | |
| 2 | A02 | Drugs for acid related disorders | |
| 3 | A02B | DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) | |
| 4 | A02BX | Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) | |
| 5 | A02BX11 | Troxipide |
| Active Ingredient | Description | |
|---|---|---|
| Troxipide |
Tripoxide is a gastric cytoprotective agent used for the treatment of gastritis and gastric uclers. Troxipide has a mode of action different from that for other anti-gastric agents: it does not inhibit acid secretion and does not have acid neutralizing activity. It exerts its activity by increasing mucus production, cytoprotective prostaglandin secretion, regeneration of collagen fibers, reducing inflammatory mediator induced neutrophil migration and reactive oxygen species generation in gastric mucosa, enhancing gastric mucosal metabolism and microcirculation. |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
